Erlotinib - Generic Drug Details
✉ Email this page to a colleague
US Patents and Regulatory Information for erlotinib
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa Inc | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 091059-003 | Aug 28, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Rising | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 091002-002 | Jun 11, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Alembic | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 214719-003 | Jul 8, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Natco Pharma Ltd | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 208488-001 | Nov 5, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |